Stay updated with breaking news from Pooled Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– New data presented at the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition meeting – Earlier treatment with Bylvay provided greater efficacy in... | October 13, 2022
Nearly three in four patients treated with adjuvant TAGRISSO were alive and disease-free at four years Exploratory results showed TAGRISSO also reduced the risk of disease recurrence in the brain or spinal cord by 76% in patients with Stage II-IIIA disease
Investegate announcements from AstraZeneca PLC, Tagrisso approved in Japan for early lung cancer
Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its dermatology portfolio will be presented at the upcoming 2022 European Academy of Dermatology and Venereology (EADV)
Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its oncology portfolio will be presented at the upcoming European Hematology Association 2022 (EHA2022) Congress (June